SEC Form 4 research
| Issuer | Cytek Biosciences, Inc. |
|---|---|
| Tickers | CTKB |
| Reporting owners | 25 |
| Officers and directors | 9 |
| Last public filing | 2026-08-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-12 | 2026-08-10 | Feuchtwang Ilan | A | 127,118 | $0 | Not reported |
| 2026-08-12 | 2026-08-10 | Feuchtwang Ilan | A | 241,416 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.